• José M Ceresetto, Cristina Duboscq, Jorge Korin, Carlos Fondevila, Patricia Casais, Andrea Rossi, Alejandra Scazziota, Marta Martinuzzo, María Esther Aris Cancela, Claudio Rosa, Gonzalo Pombo, Carla Guimelli, Yolanda Adamczuk, Alejandra Martí, Diana Penchasky, Dardo Riveros, Dolores Puente, Lucía Celebrin, Soledad Molnar, Susana Meschengieser, Miguel Castro Ríos, Alicia Blanco, Héctor Hendler, Andrés Brodsky, Analía Sánchez Luceros, Pedro Negri Aranguren, José Luis Fedele, Claudio Merlo, Pablo Raña, Carina Gumpel, Cecilia Colorio, Beatriz Grand, Virginia Canónico, Eleonora Rossi, Paulo Colimodio, Sergio Orlando, Daniel Fassi, Mirta Arias, Laura Viudez, Roberto Farreras, Pablo Martínez, Hugo Ferro, Claudia Casali, Alejandra Baques, Guillermo Arbesú, Susana Viñuales, Fernanda Medina, Verónica Cortés, María Del Carmen Gallo, Ludmila Ehelou, Luis Barrera, Irene Rey, Gabriela de Larrañaga, Flavia Figueroa, Alicia Vilaseca, Isabel Kuri, Alberto Maneyro, María Otaran, David Luis Xavier, Susana Garbiero, Julieta Salviú, Patricia Fontenla, Andrea Eckhardt, Carolina Bomparola, and Laura Fornasiero.
• Hospital Británico de Buenos Aires, Argentina. E-mail: jceresetto@intramed.net.
• Medicina (B Aires). 2020 Jan 1; 80 Suppl 4: 1-26.

AbstractTreating an anticoagulated patient with vitamin K antagonists (VKA) remains a challenge, especially in areas where dicoumarins are still the first drug of choice due to the cost of other oral anticoagulants. Anticoagulation clinics have proven to be the most efficient and safe way to avoid thrombotic and hemorrhagic complications and to keep patients in optimal treatment range. However, they require adequate infrastructure and trained personnel to work properly. In this Argentine consensus we propose a series of guidelines for the effective management of the anticoagulation clinics. The goal is to achieve the excellence in both the clinical healthcare and the hemostasis laboratory for the anticoagulated patient. The criteria developed in the document were agreed upon by a large group of expert specialists in hematology and biochemistry from all over the country. The criteria presented here must always be considered when indicating VKA although they had to be adapted to the unequal reality of each center. Taking these premises into consideration will allow us to optimize the management of the anticoagulated patient with VKA and thus minimize thrombotic and hemorrhagic intercurrences, in order to honor our promise not to harm the patient.

19 keywords...

hide…